Bibliographic Details
| Title: |
Olfactory Dysfunction—A Potential Biomarker of Neurological Involvement in Wilson's Disease. |
| Authors: |
Bembenek, Jan1 (AUTHOR) jbembenek@o2.pl, Antos, Agnieszka2 (AUTHOR), Członkowska, Anna2 (AUTHOR), Litwin, Tomasz2 (AUTHOR) |
| Source: |
Movement Disorders Clinical Practice. Mar2025, Vol. 12 Issue 3, p398-399. 2p. |
| Subject Terms: |
*BIOMARKERS, *CENTRAL nervous system, *RESEARCH questions, *SMELL disorders, *HEPATOLENTICULAR degeneration, *COPPER industry, *NEUROPHYSIOLOGY |
| Abstract: |
The article discusses olfactory impairment (OI) as a potential biomarker for neurological involvement in Wilson's disease (WD), an inherited disorder of copper metabolism. While some studies suggest OI could serve as a biomarker for central nervous system (CNS) involvement in WD, the current study did not find significant differences in olfactory thresholds between WD patients and healthy controls. Further research with larger patient groups and standardized methodologies is needed to determine the utility of OI as a biomarker for neurological involvement in WD management. [Extracted from the article] |
|
Copyright of Movement Disorders Clinical Practice is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Academic Search Complete |
